Ohio State Navbar

Directory

Anthony Michaels, MD


395 W 12th Ave
Columbus, OH 43210

Email: michaels.35@osu.edu

 

Current OSU Appointments

Assistant Professor-Clinical, Gastro, Hepatology & Nutrition

Physician, FGP-Gastro-Hepatology & Nutr'n

 

Biographical

Since joining as a faculty member in the department of Gastroenterology and Hepatology (GHN) at The Ohio State Wexner Medical Center I have been focused on strengthening and building our Hepatology division as well as our Liver Transplant program. I have successfully been able to do this through several ways.

The largest contribution that I have made to our GHN division as well as the liver transplant department has been my focus as a clinician. Through my contributions in my clinical practice as well as my dedication to our inpatient Hepatology service and Hepatology consult team, our general Hepatology referrals have increased by, our liver transplant referrals have increased by , and we have met or exceeded the goal of liver transplants done at our medical center every year. In fact, we have done more liver transplants in the 2016 calendar year than in any other previous year at this medical center, while also maintaining nationally recognized graft and patient survival outcomes.

Through this busy clinical schedule I have been able to exceed my wRVU target. In the 2016 Academic Year, I was >3000 wRVUs over my target. This demonstration in excellence in clinical care in our GHN and liver transplant departments has lead to my current appointments as the Medical Director of Liver Transplantation as well as the physician leader of the GHN Practice Management Committee. Since taking on the Practice Management lead, the patients waiting to be seen in our Hepatology clinics has significantly decreased; greater than 1000 patients to a now more manageable less than 50 patients on a consistent basis. Our Hepatology clinic access has also significantly improved from greater than 6 months to less 3 months for general Hepatology patients to less than 2 weeks for liver transplant referrals.

Besides increasing the number of referrals, activations and liver transplantations at our medical center, my role as the Medical Director of Liver Transplantation has also focused on improving the care of these patients pre and post transplant. I serve as the chairman of our Liver Care group that meets monthly to discuss areas of improvement in our pretransplant process including updating our current protocols, which also developing new protocols that align with the current standard of care. I also serve on the Liver Quality committee that also meets monthly and focuses on the improvement of care in our post transplant patients. I also serve as one of the Co-Chairs in our Patient Progress meeting that meets weekly to improve the efficiency of our liver transplant referral process. Since I started this meeting, our time from referral to liver transplant activation has decreased by over 30%. I am also part of the biweekly committee that reviews our higher risk post transplant patients. All of these committees serve the purpose of improving the quality of care that our pre and post liver transplant patients receive at our medical center.

I will continue to strive to help lead our liver transplant program, while also increasing our hepatology referrals with continued outreach and improving upon our clinic access. Our medical center is well on our way in becoming a liver transplant center that is no longer just locally recognized.

Licenses

2009 - present Board Certified: American Board of Internal Medicine
2010 - present Board Certified: American Board of Internal Medicine
2010 - present Certified: Advanced Cardiac Life Support
2006 - 2016 Board Certified: American Board of Internal Medicine
 

Chapters in Books

N-Acetylcysteine has not been shown to be effective for all non acetaminophen acute liver failure

 

Conferences

Cyclosporine helps to achieve a higher SVR in patients receiving PEG-interferon/ribavirin for recurrent hepatitis C after liver transplantation: Final analysis of a randomized-controlled study

THE IMPACT OF PRESERVATION INJURY ON ACCELERATED HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

Noninvasive Rapid Acquisition Technique for Hepatic Fibrosis using Magnetic Resonance Elastography

Cryptosporodium Enteritis in a Liver Transplant Patient

Outcomes of Transjugular Intrahepatic Porto-Systemic Shunt (TIPSS) in patients waiting and after liver transplantation: Study based on the UNOS database.

Rotational Thromboelastometry (ROTEM) versus Conventional Coagulation Tests during Orthotopic Liver Transplantation: Comparison of Intra-operative Blood Loss, Transfusion Requirements, and Cost

Coronary Angiography in Patients being evaluated for Orthotopic Liver Transplantation

Trends and Outcomes of Transarterial Chemoembolization (TACE) for Primary Hepatocellular Cancers (HCC): Evidence From the 2002-2012 Nationwide Inpatient Sample

Tenofovir-Induced Fanconi Syndrome

 

Degrees

1997 B.A., Kalamazoo College

2003 M.D., The Ohio State University

 

Honors

2001 Honors Program.
2001 - 2002 Letter of Commendation.
2002 Honors Program.
2002 Letter of Commendation.
2002 Letter of Commendation.
2002 Letter of Commendation.
2002 - 2003 Honors Program.
2003 Letter of Commendation.
2004 American Liver Fdtn & American Assn for the Study of Liver Diseases Resident Scholar Travel Award.
 

Journal Articles

. -.

 

Reference Works

October 2010 Michaels A, Dhanasekaran R, Alkhasawneh A, et al.."The impact of preservation injury on accelerated hepatitis C recurrence after liver transplantation" .
November 2013 Patwa L, Stanich P, Booty J, Michaels A, et al.."Body Mass Index (BMI) Correlates Poorly with Visceral Adiposity in End- Stage Liver Disease" .
October 2015 Hatch A, Michaels A, Pfeil S.."Spontaneous Bacterial Peritonitis: The Importance of Early Diagnostic Paracentesis." .
October 2015 Peck J, Hussan H, Latchana N, Hanje J, Michaels A, et al.."Morbid Obesity Does Not Impact Healthcare Utilization and Costs of Orthotopic Liver Transplantation" .
October 2016 Sanderson R, Michaels A."Constrictive Pericarditis of Unknown Etiology Causes Signifiant Ascites in the Absence of Liver Disease" .

Presentations

Managing Complications of Cirrhosis

New Horizons in Hepatitis C Treatment

Ascites

Acute Hepatitis and Massive/Submassive Necrosis

Primary Biliary Cirrhosis an Overlapping Biliary Disease

Therapeutic Options for Hepatitis C

Review of Best Practices

Primary Biliary Cirrhosis an Overlapping Biliary Disease

Update in the Management of Hepatitis C

Update in the Treatment of Hepatitis C

Viral Hepatitis

Hepatitis C

Hepatitis C: New Therapeutic Options

Abnormal Liver Function Tests

Hepatitis C Diagnosis and Treatment

Updates in the Management of Hepatitis C

Update in the Management of Hepatitis C

The GHN Experience in the Management of Hepatitis C

Approaching the Patient with Abnormal Liver Function Tests

Approaching the Patient with Abnormal Liver Function Tests

Bile Formation and Secretion

Approaching the Patient with Abnormal Liver Function Tests

Update in the Management of Hepatitis C

Fighting Chronic Hepatitis C Infection on Multiple Fronts in the Department of Veteran's Affairs: Integrating New Multi-Targeted Therapies to Improve Patient Adherence and Response

Primary Care Management of Viral Hepatitis

New Era for Viral Hepatitis Management

Taking Steps to Improve the Management of Chronic HCV

Fighting Chronic Hepatitis C Infection on Multiple Fronts in the Department of Veteran's Affairs: Integrating New Multi-Targeted Therapies to Improve Patient Adherence and Response

New Directions in the Treatment of Hepatitis C

Viral hepatitis.

Primary biliary cirrhosis.

 

Unpublished Works

Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect.